#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glomerulonephritis acute Factor IX deficiency Craniocerebral injury Fibrosarcoma Gastric cancer Exudative retinopathy Cerebral amyloid angiopathy Hidradenitis Acute myeloid leukaemia recurrent Kearns-Sayre syndrome Pulmonary hypertension Transitional cell cancer of the renal pelvis and ureter Chorioretinitis Glioma Ductal adenocarcinoma of pancreas More trials…

    Learn about Rare Diseases

    Osteosarcoma recurrent – Trials in Disease Chondrosarcoma metastatic – Diagnostics Myelodysplastic syndrome – Life with Disease Rhabdomyosarcoma recurrent – Life with Disease Optic glioma – Trials in Disease Fragile X syndrome – Life with Disease Osteosarcoma – Life with Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Retinitis pigmentosa Mucopolysaccharidosis I – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Promethazine Hydrochloride BUDOPRUTUG Indocyanine Green HYDROGEN PEROXIDE Levocarnitine ZINC GLUCONATE Etifoxine Hydrochloride Caplacizumab BROLUCIZUMAB Tulmimetostat CITRIC ACID ANHYDROUS Sodium Cromoglicate Eribulin RUBIDIUM CHLORIDE Threonine PEGVISOMANT Lisocabtagene Maraleucel Iodixanol Mbf-118 Topiramate More therapies…

    Learn about Your Condition

    Varicella Herpes virus infection Gaucher's disease type I Bronchiolitis Cushing's syndrome Gastrointestinal melanoma Nodal osteoarthritis Primary hypercholesterolaemia Encephalitis Japanese B Poor quality sleep Ovarian cancer metastatic Myasthenia gravis Haemorrhage prophylaxis Type IIa hyperlipidaemia Uveal melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Evaluating venetoclax with drug combination in relapsed/refractory T‑cell acute lymphoblastic leukemia patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • T-cell type acute leukaemia
    Investigated Drugs:
    • Tofacitinib
    • Everolimus
    • Venetoclax
    Czechia France Germany The Netherlands Spain

  • Methoxyflurane versus oral oxycodone hydrochloride and morphine sulfate for pain relief in sickle cell disease vaso‑occlusive crises

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • Morphine Sulfate
    • Oxycodone Hydrochloride
    France

  • Celecoxib versus placebo for pain and quality of life in adult patients with chronic pancreatitis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Pancreatitis chronic
    Investigated Drugs:
    • Celecoxib
    • Pantoprazole Sodium Sesquihydrate
    Denmark

  • Safety and Efficacy of VX-828, Deutivacaftor, and Tezacaftor in Adults with Cystic Fibrosis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cystic fibrosis
    Belgium Czechia Denmark France Germany Ireland +5

  • Phase II Study of Intratumoral Hydrogen Peroxide (KRC-01) Combined with Radiotherapy for Locally Advanced Rectal Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Rectal adenocarcinoma
    Investigated Drugs:
    • HYDROGEN PEROXIDE
    France

  • Shortening treatment duration in adults with uncomplicated candidemia: caspofungin acetate versus saline and sodium lactate placebo

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Systemic candida
    Investigated Drugs:
    • Sodium Lactate
    • Caspofungin Acetate
    • Saline
    Germany
Previous Page
1 … 704 705 706 707 708 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!